4DMedical Limited
FDMDF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $74 | $201 | $238 | $341 |
| - Cash | $7 | $31 | $70 | $51 |
| + Debt | $4 | $5 | $5 | $6 |
| Enterprise Value | $72 | $176 | $173 | $296 |
| Revenue | $6 | $3 | $1 | $1 |
| % Growth | 91.9% | 324.4% | -31.8% | – |
| Gross Profit | $5 | $3 | -$24 | $0 |
| % Margin | 92.1% | 92.2% | -3,378.6% | 26.6% |
| EBITDA | -$46 | -$32 | -$44 | -$35 |
| % Margin | -786.7% | -1,044.6% | -6,099.9% | -3,343.9% |
| Net Income | -$30 | -$36 | -$31 | -$25 |
| % Margin | -513.7% | -1,179.8% | -4,378% | -2,332.6% |
| EPS Diluted | -0.14 | -0.097 | -0.1 | -0.084 |
| % Growth | -44.2% | 2.9% | -19.8% | – |
| Operating Cash Flow | -$34 | -$31 | -$23 | -$25 |
| Capital Expenditures | -$0 | -$0 | -$2 | -$3 |
| Free Cash Flow | -$35 | -$31 | -$24 | -$28 |